If it succeeds, it would not only help stroke patients, but bring more money to TSRI's top -
rated biomedical research.
Not exact matches
You can observe this happening, and understanding the
rates at which this happens is vital for the progress of
biomedical research, the fruits of which you enjoy when you take medication.
Technological breakthroughs in the last 10 years have led to rapid increases in the volume and
rate of
biomedical research, which in turn has led to a rapid growth in
biomedical knowledge.
Now comes a first
rate example of how CRISPR is changing the pace of
biomedical research by linking up with another cutting edge technology — human pluripotent stem cells (hPSCs).
I'm guessing the methodological requirements of subjective
rating studies might not have been obvious or intuitive to people who don't design, perform, or review such studies (although similar requirements in
biomedical research seem to be widely understood.)